High ME1 Expression Is a Molecular Predictor of Post-Transplant Survival of Patients with Acute Myeloid Leukemia
Authors:
- César Alexander Ortiz RojasCRCésar Alexander Ortiz Rojas
- Abel Costa-NetoACAbel Costa-Neto
- Diego A. Pereira-MartinsDPDiego A. Pereira-Martins
- Duy Minh LeDLDuy Minh Le
- Dominique SternadtDSDominique Sternadt
- Isabel WeinhäuserIWIsabel Weinhäuser
- Gerwin HulsGerwin Huls
- Jan Jacob SchuringaJSJan Jacob Schuringa
- Eduardo Magalhães RegoEREduardo Magalhães Rego
Open Access
Abstract
Several laboratory and clinical variables have been reported to be associated with the outcome of intensive chemotherapy for acute myeloid leukemia (AML), but only a few have been tested in the context of hematopoietic stem cell transplant (HSCT). This study aimed to identify genes whose expression of AML at diagnosis were associated with survival after HSCT. For this purpose, three publicly available adult AML cohorts (TCGA, BeatAML, and HOVON), whose patients were treated with intensive chemotherapy and then subjected to allogeneic or autologous HSCT, were included in this study. After whole transcriptome analysis, we identified ME1 as the only gene whose high expression was associated with shorter survival in patients subjected to HSCT. In addition, the inclusion of ME1 expression was able to improve the European LeukemiaNet risk stratification. Pathways related to lipid biosynthesis, mainly fatty acids, and cholesterol were positively correlated with ME1 expression. Furthermore, ME1 expression was associated with an M2 macrophage-enriched microenvironment, mature AML blasts hierarchy, and oxidative phosphorylation metabolism. Therefore, ME1 expression can be used as biomarker of poor response to HSCT in AML.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/08135-2, 2017/08430-5, 2017/23117-1, 2015/09228-0)
- Graduate School of Medical Sciences of the University of Groningen/University Medical Center Groningen (UG/UMCG) (2013/08135-2, 2017/08430-5, 2017/23117-1, 2015/09228-0)
This publication has 55 references indexed in Scilit:
- Robust enumeration of cell subsets from tissue expression profilesNature Methods, 2015
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaNew England Journal of Medicine, 2013
- Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescenceNature, 2013
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cellsNucleic Acids Research, 2012
- Comparative Analysis of the Value of Allogeneic Hematopoietic Stem-Cell Transplantation in Acute Myeloid Leukemia With Monosomal Karyotype Versus Other Cytogenetic Risk CategoriesJournal of Clinical Oncology, 2012
- High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemiaBlood, 2010
- Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profilingHaematologica, 2009
- Hematopoietic-Cell Transplantation at 50New England Journal of Medicine, 2007
- Cytosolic and Mitochondrial Malic Enzyme Isoforms Differentially Control Insulin SecretionJournal of Biological Chemistry, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005